Restructuring the FDA’s Food Program: Promises and Pitfalls

Abstract

Following an outbreak of Cronobacter sakazakii infection in infant formula, the US Food and Drug Administration commissioned a series of reports and then undertook a major reorganization of its food program. This article describes the changes that went into effect on 1 October 2024, why those changes are likely to improve the new Human Foods Program, and additional work that must be undertaken to enhance the agency’s impact upon public health.

Keywords

• US Food and Drug Administration
• reorganization
• public policy
• regulation
• infant formula
• Human Foods Program